Provider FAQ

Our molecular UTI panel tests for 31 clinically relevant causative pathogens, 34 antimicrobial resistance genes, and multiple different antibiotics for phenotypic susceptibility (variable, based on organism(s) detected and pathogen load meeting reflex criteria), 

Pathogens: 

• Acinetobacter baumanii
• Candida albicans
• Candida glabrata
• Candida parapsilosis
• Chlamydia trachomatis
• Citrobacter freundii
• Citrobacter koseri
• Enterobacter aerogenes
• Enterobacter cloacae
• Enterococcus faecalis
• Enterococcus faecium
• Escherichia coli
• Gardnerella vaginalis
• Klebsiella oxytoca
• Klebsiella pneumoniae
• Morganella morganii
• Mycoplasma genitalium
• Mycoplasma hominis
• Neisseria gonorrhoea
• Pantoea agglomerans 
• Proteus mirablis
• Proteus vulgaris
• Providencia stuartii
• Pseudomonas aeruginosa
• Serratia marcescens
• Staphylococcus aureus
• Staphylococcus epidermidis
• Staphylococcus species
• Streptococcus agalactiae (Group B Strep)
• Ureaplasma parvum
• Ureaplasma urealyticum

Antibiotic Resistance Genes:

• Beta-lactamase and ESBL: blaACC/blaACT, CTX-M Group I, CTX-M Group II, DHA/MIR, FOX/MOX, SHV/VEB, TEM/GES, PER 
• Carbapenem: NDM/IMP, KPC, OXA-1/OXA-48, OXA-23, VIM  
• Macrolide-Lincosamide-Streptogramin B (MLSB): Erm A/Erm B, Erm C
• Methicillin: mecA  
• Quinolone and Fluoroquinolone: QnrA/QnrB/QnrS  
• Sulfonamide:  Sul2  
• Tetracycline: tet(M)  
• Trimethoprim: dfrA5/A1  
• Vancomycin: VanA/VanC, VanB  

Here is an example sample report showing a polymicrobial UTI with both microbe identification and molecular antibiotic susceptibility results.